Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Mexico - Delayed Quote MXN

SPDR S&P Biotech ETF (XBI.MX)

1,595.50
0.00
(0.00%)
At close: April 29 at 9:19:45 AM CST

Top 10 Holdings (26.04% of Total Assets)

SymbolCompany% Assets
Alnylam Pharmaceuticals, Inc. 2.88%
Insmed Incorporated 2.67%
Neurocrine Biosciences, Inc. 2.62%
United Therapeutics Corporation 2.60%
Amgen Inc. 2.58%
AbbVie Inc. 2.56%
Gilead Sciences, Inc. 2.54%
Natera, Inc. 2.53%
Vertex Pharmaceuticals Incorporated 2.53%
Biogen Inc. 2.53%

Sector Weightings

SectorXBI.MX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.91%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.31
Price/Sales 0.17
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

ETF Overview

Category Health
Fund Family SPDR State Street Global Advisors
Net Assets 5.12B
YTD Daily Total Return --
Yield --
Legal Type Exchange Traded Fund

Related Tickers